Secondary Myelodysplastic Syndromes: Clinical Trials

61 trials for Secondary Myelodysplastic Syndromes, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

51 completed, 7 terminated, 2 withdrawn, 1 active not recruiting. 30 Phase 2, 18 Phase 1, 7 Not applicable, 6 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 230Completed 25, Terminated 4, Withdrawn 1
Phase 118Completed 16, Terminated 2
Not applicable7Completed 5, Terminated 1, Withdrawn 1
Phase 36Completed 6

Follow Secondary Myelodysplastic Syndromes: new trials by email Literature Review of Secondary Myelodysplastic Syndromes trials Research Report on Secondary Myelodysplastic Syndromes

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Organ-Sparing Marrow-Targeted Irradiation Before Stem Cell Transplant in Treating Patients With High-Risk Hematologic Malignancies
radiation therapy, cyclophosphamide, anti-thymocyte globulin - Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in Remission
Phase 1CompletedSumithira Vasu332015-07-272023-09-21
CPX-351 in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome
liposomal cytarabine-daunorubicin CPX-351 - Adult Acute Erythroid Leukemia (M6), Adult Acute Megakaryoblastic Leukemia (M7)
Phase 2CompletedRondeep Brar112014-02-032019-01-22
Single or Double Donor Umbilical Cord Blood Transplant in Treating Patients With High-Risk Hematologic Malignancies
cyclophosphamide, fludarabine phosphate, mycophenolate mofetil - Accelerated Phase Chronic Myelogenous Leukemia, Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome
Phase 2WithdrawnUniversity of Medicine and Dentistry of New Jersey2014-01-012016-07-14
Donor T Cells After Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies
therapeutic allogeneic lymphocytes, laboratory biomarker analysis - Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities
Phase 2CompletedUniversity of Chicago772013-04-042019-08-07
Vaccine Therapy in Preventing Cytomegalovirus Infection in Patients With Hematological Malignancies Undergoing Donor Stem Cell Transplant
tetanus-CMV fusion peptide vaccine, laboratory biomarker analysis - Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission
Phase 1CompletedCity of Hope Medical Center362012-10-292024-04-02
Mechanical Stimulation in Preventing Bone Density Loss in Patients Undergoing Donor Stem Cell Transplant
management of therapy complications, musculoskeletal complications management/prevention - Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission
Not applicableWithdrawnRoswell Park Cancer Institute2012-05-012012-07-09
Tosedostat in Combination With Cytarabine or Decitabine in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
tosedostat, cytarabine, decitabine - Acute Myeloid Leukemia With Multilineage Dysplasia, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities
Phase 2CompletedFred Hutchinson Cancer Center342012-05-012017-02-15
Fludarabine Phosphate, Melphalan, and Low-Dose Total-Body Irradiation Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies
fludarabine phosphate, melphalan, total-body irradiation - Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission
Phase 2CompletedRoswell Park Cancer Institute942012-02-282019-09-24
Cyclophosphamide for Prevention of Graft-Versus-Host Disease After Allogeneic Peripheral Blood Stem Cell Transplantation in Patients With Hematological Malignancies
cyclophosphamide, cyclosporine, peripheral blood stem cell transplantation - Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission
Phase 2CompletedFred Hutchinson Cancer Center432011-09-012017-05-19
A Two-Step Approach to Reduced Intensity Bone Marrow Transplant for Patients With Hematological Malignancies
Fludarabine, Busulfan, Total Body Irradiation (TBI) - Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in Remission
Phase 2CompletedSidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University402011-08-042026-04-15
Supersaturated Calcium Phosphate Rinse in Preventing Oral Mucositis in Young Patients Undergoing Autologous or Donor Stem Cell Transplant
supersaturated calcium phosphate rinse, placebo, questionnaire administration - Childhood Acute Lymphoblastic Leukemia in Remission, Childhood Acute Myeloid Leukemia in Remission
Phase 3CompletedChildren's Oncology Group2262011-03-012019-09-17
Infection Prophylaxis and Management in Treating Cytomegalovirus (CMV) Infection in Patients With Hematologic Malignancies Previously Treated With Donor Stem Cell Transplant
infection prophylaxis and management, laboratory biomarker analysis, flow cytometry - Hematopoietic/Lymphoid Cancer, Accelerated Phase Chronic Myelogenous Leukemia
Active not recruitingCity of Hope Medical Center1532011-01-112026-10-22
Palifermin in Preventing Chronic Graft-Versus-Host Disease in Patients Who Have Undergone Donor Stem Cell Transplant for Hematologic Cancer
palifermin, flow cytometry, laboratory biomarker analysis - Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission
Not applicableCompletedMartin, Paul62010-09-012014-04-02
Infusion of Off-the-Shelf Expanded Cord Blood Cells to Augment Cord Blood Transplant in Patients With Hematologic Malignancies
umbilical cord blood transplantation, fludarabine phosphate, cyclophosphamide - Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Myeloid Leukemia in Remission
Phase 2CompletedNohla Therapeutics, Inc.152010-08-012019-03-05
Deferasirox for Treating Patients Who Have Undergone Allogeneic Stem Cell Transplant and Have Iron Overload
deferasirox - Iron Overload, Accelerated Phase Chronic Myelogenous Leukemia
Phase 2TerminatedCity of Hope Medical Center12010-07-012019-06-18
Plerixafor and Filgrastim For Mobilization of Donor Peripheral Blood Stem Cells Before A Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies
plerixafor, filgrastim, peripheral blood stem cell transplantation - Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission
Not applicableTerminatedFred Hutchinson Cancer Center12010-06-012017-06-28
Azacitidine in Treating Patients With Relapsed Myelodysplastic Syndrome, Chronic Myelomonocytic Leukemia, or Acute Myeloid Leukemia Who Have Undergone Stem Cell Transplant
azacitidine, laboratory biomarker analysis - Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q)
Phase 2CompletedFred Hutchinson Cancer Center432010-04-012017-05-24
5-Fluoro-2'-Deoxycytidine and Tetrahydrouridine in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndromes
5-fluoro-2-deoxycytidine, tetrahydrouridine, laboratory biomarker analysis - Adult Acute Myeloid Leukemia, de Novo Myelodysplastic Syndromes
Phase 1CompletedCity of Hope Medical Center252009-12-222026-10-16
Rituximab in Preventing Acute Graft-Versus-Host Disease in a Donor Stem Cell Transplant for Hematologic Cancer
rituximab, mycophenolate mofetil, tacrolimus - Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission
Phase 2TerminatedUniversity of Nebraska202009-12-102023-09-06
Identification of de Novo Fanconi Anemia in Younger Patients With Newly Diagnosed Acute Myeloid Leukemia
laboratory biomarker analysis - Childhood Acute Erythroleukemia (M6), Childhood Acute Megakaryocytic Leukemia (M7)
CompletedChildren's Oncology Group202009-05-012016-05-17

Showing 20 of 61. Sign in to see all of them.

Narrower conditions

Congenital Abnormalities (44)  ·  Leukemia, Myeloid, Acute (43)  ·  Precursor Cell Lymphoblastic Leukemia-Lymphoma (39)  ·  Leukemia, Myelomonocytic, Chronic (34)  ·  Blast Crisis (27)  ·  Leukemia, Lymphocytic, Chronic, B-Cell (26)  ·  Leukemia, Myeloid, Accelerated Phase (26)  ·  Burkitt Lymphoma (25)  ·  Lymphoma, B-Cell, Marginal Zone (24)  ·  Lymphoma, Follicular (24)  ·  Myeloproliferative Disorders (24)  ·  Leukemia, Myeloid, Chronic-Phase (23)  ·  Lymphoma, Large B-Cell, Diffuse (23)  ·  Lymphoma, Mantle-Cell (23)  ·  Lymphoma, Non-Hodgkin (23)

Broader conditions

Hematologic Diseases (57)  ·  Hemic and Lymphatic Diseases (57)  ·  Leukemia, Myeloid (56)  ·  Neoplasms (56)  ·  Neoplasms by Histologic Type (56)  ·  Leukemia (55)  ·  Bone Marrow Diseases (53)  ·  Chronic Disease (49)  ·  Disease Attributes (49)  ·  Pathologic Processes (49)  ·  Pathological Conditions, Signs and Symptoms (49)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (47)  ·  Immune System Diseases (39)  ·  Immunoproliferative Disorders (39)  ·  Leukemia, Lymphoid (39)

Interventions

fludarabine phosphate (16)  ·  Whole-Body Irradiation (14)  ·  Cyclophosphamide (13)  ·  Mycophenolic Acid (13)  ·  Peripheral Blood Stem Cell Transplantation (13)  ·  Cyclosporine (10)  ·  Tacrolimus (10)  ·  Transplantation (9)  ·  Busulfan (8)  ·  Methotrexate (8)  ·  merphos (8)  ·  Cytarabine (6)  ·  Flow Cytometry (5)  ·  Therapeutics (5)  ·  Antilymphocyte Serum (4)

Sponsors

National Cancer Institute (NCI) (21)  ·  Fred Hutchinson Cancer Center (17)  ·  Children's Oncology Group (5)  ·  City of Hope Medical Center (4)  ·  Roswell Park Cancer Institute (3)  ·  Case Comprehensive Cancer Center (2)  ·  Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium (1)  ·  Martin, Paul (1)  ·  Nohla Therapeutics, Inc. (1)  ·  Rondeep Brar (1)  ·  Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University (1)  ·  Sumithira Vasu (1)  ·  University of Chicago (1)  ·  University of Medicine and Dentistry of New Jersey (1)  ·  University of Nebraska (1)

Countries

United States (59)  ·  Canada (4)  ·  Australia (2)  ·  Germany (1)  ·  Italy (1)  ·  Puerto Rico (1)

Top investigators

Bart Scott (3)  ·  Francis Giles (3)  ·  Paul Martin (3)  ·  Colleen Delaney (2)  ·  George Chen (2)  ·  Johnnie Orozco (2)  ·  Mark Kirschbaum (2)  ·  Ryotaro Nakamura (2)  ·  Alvaro Moreno Aspitia (1)  ·  Amanda Cashen (1)  ·  Andrew Rezvani (1)  ·  Ann Woolfrey (1)  ·  B. Smith (1)  ·  Beverly Lange (1)  ·  Boglarka Gyurkocza (1)

Results publications

PMID 18698002, PMID 19304957, PMID 19786617, PMID 20056794, PMID 20413658, PMID 21149673, PMID 21791475, PMID 26764356, PMID 26853648, PMID 28389462, PMID 28817727, PMID 30562587, PMID 32628342, PMID 33420905, PMID 35445027, PMID 36282798, PMID 36815378, PMID 38295280, PMID 42085603

NIH funding

P30CA015704 (8), U10CA098543 (4), P01CA018029 (3), P01HL036444 (3), U01CA062461 (3), U01CA062505 (3), U01CA070095 (3), N01CM62202 (2), N01CM62203 (2), N01CM62205 (2), P01CA078902 (2), P30CA015083 (2), RC2HL101844 (2), U01CA062502 (2), K23HL084054 (1)